A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00416273
Recruitment Status : Completed
First Posted : December 27, 2006
Last Update Posted : March 6, 2015
Information provided by (Responsible Party):
Janssen-Cilag G.m.b.H

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2013
  Actual Study Completion Date : May 2013